ロード中...
Clinical utility of FDG PET in Parkinson’s disease and atypical parkinsonism associated with dementia
PURPOSE: There are no comprehensive guidelines for the use of FDG PET in the following three clinical scenarios: (1) diagnostic work-up of patients with idiopathic Parkinson’s disease (PD) at risk of future cognitive decline, (2) discriminating idiopathic PD from progressive supranuclear palsy, and...
保存先:
| 出版年: | Eur J Nucl Med Mol Imaging |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer Berlin Heidelberg
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6061481/ https://ncbi.nlm.nih.gov/pubmed/29779045 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-018-4031-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|